Organization · Venture Capital
Healthspan Capital
Healthspan Capital is an early-stage venture capital firm based in El Cerrito, California, specializing in longevity biotechnology and regenerative medicine. It operates as an AngelList Rolling Fund, focusing on investments in companies developing therapeutics aimed at extending healthy human lifespan.
Overview
What Healthspan Capital does
What Healthspan Capital is
Healthspan Capital is an early-stage venture capital firm based in El Cerrito, California, specializing in longevity biotechnology and regenerative medicine. It operates as an AngelList Rolling Fund, focusing on investments in companies developing therapeutics aimed at extending healthy human lifespan.
How it participates in the startup ecosystem
The current public profile supports funder and publisher capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2021
- Approximate age
- About 5 years
- Structured capabilities
- Funder · Publisher
- Last reviewed
- April 9, 2026
Official channels
Find Healthspan Capital elsewhere
Open the official website or a supported primary organization account.
Capability profile
Healthspan Capital as a funder
Investment thesis
Rejuvenation is the future of medicine, targeting biotechnology startups developing therapies to slow or reverse aging.
Focus narrative
Healthspan Capital invests in early-stage longevity biotech companies, specifically those developing therapeutics that target aging. The firm focuses on investments ranging from pre-Seed to Series A stages.
Value beyond capital
Healthspan Capital provides value to its portfolio companies through a strong network in the longevity community, access to industry expertise, and support in navigating the complexities of biotechnology development.
Terms and economics
- Typical check
- $5,000
Focus and fit
- Stages
- Pre-seed · Seed · Series A
- Regions
- North AmericaUnited States
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 25
Portfolio context
Notable portfolio companies include: Shift Bioscience (cellular age reversal), Deciduous Therapeutics (senolytic drugs), Equator Therapeutics (aging interventions), Repair Biotechnologies (rejuvenation therapies), Immunis (immune system aging), Samsara Therapeutics (autophagy modulation), Molecule (longevity biotech DAO/platform), KetoSwiss (metabolic health), and others like Zoe Biosciences, Vincere, and Weatherwax Bio.
Capability profile
Healthspan Capital as a publisher
Editorial focus
Healthspan Capital is a venture capital firm that focuses on early-stage investments in longevity biotechnology companies. The firm targets startups developing therapeutics aimed at extending healthy human lifespan, specifically in the areas of cellular reprogramming, senolytic therapies, and regenerative medicine. Founded in 2021, it operates as an AngelList Rolling Fund, making it the first publicly accessible longevity venture fund listed on AngelList.
Audience value
Healthspan Capital provides investors with access to early-stage longevity biotech companies, leveraging a rolling fund structure that lowers barriers to entry. The firm aims to capitalize on the growing market for longevity therapeutics, which is projected to see significant capital inflow and innovation.
Format and cadence
- Primary platform
- AngelList
- Cadence
- quarterly
Availability
- Guest pitch state
- Not currently accepting
Audience and focus
- Audience
- Investors
- Regions
- North AmericaUnited States
Flagship work and coverage
Flagship properties
Healthspan Capital operates as an AngelList Rolling Fund, allowing accredited investors to subscribe and invest on a quarterly basis. The firm is noted for its active investment strategy in the longevity biotech sector, with over 30 deals in under two years.
Notable coverage
Healthspan Capital has been featured in various articles on longevity technology and has sponsored the Aging Research & Drug Discovery Conference (ARDD 2024). Nathan Cheng, one of the General Partners, hosts The Longevity Biotech Show podcast, further establishing the firm's presence in the longevity community.
Common questions
What to know about Healthspan Capital
Upseed classifies Healthspan Capital under the Venture Capital organization type. Its current public profile includes funder and publisher capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 9, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.